Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A novel quantitative computer-assisted drug-induced liver injury causality assessment tool (DILI-CAT)

PLoS ONE(2022)10.1371/journal.pone.0271304Source: DataRank Database

A novel quantitative computer-assisted drug-induced liver injury causality assessment tool (DILI-CAT) is a research paper published in PLoS ONE (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.68)OA: goldTopics (42)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Ayako Suzuki ORCID,Michael Merz ORCID,Richard Hermann ORCID,Don C. Rockey ORCID,Hans L. Tillmann ORCID

Live enrichment

PubMed:36174069 PMC:PMC9521919 OpenAlex:https://openalex.org/W4297990394

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: P30 DK123704.

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: P20 GM 130457

NIDDK NIH HHS

Grant: P30 DK123704

National Institutes of Health

Grant: 5P30DK123704-03

MUSC Digestive Disease Research Core Center

National Institutes of Health

Grant: 3P20GM130457-02S1

CDLD Administrative Supplement for Equipment

FWCI

0.68

Citation Percentile

0.7%

Citation Trend

2022

2023

2024

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0271304&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0271304&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0271304

journalhttps://doi.org/10.1371/journal.pone.0271304

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36174069

Fields of Study

Drug-Induced Hepatotoxicity and ProtectionPharmacovigilance and Adverse Drug ReactionsPharmacogenetics and Drug Metabolism0301 basic medicine0303 health sciences03 medical and health sciencesAmoxicillin-Potassium Clavulanate CombinationCausalityCefazolinChemical and Drug Induced Liver InjuryComputersCyproteroneHumans

MeSH Terms

CefazolinComputersCyproteroneHumansCausalityAmoxicillin-Potassium Clavulanate CombinationChemical and Drug Induced Liver Injury

Keywords

MedicineCefazolinInternal medicineDrugGastroenterologyPharmacologyBiologyAntibioticsGeneticsDrug-induced liver injuryComputersScienceQRDrug specific phenotypesAmoxicillin-Potassium Clavulanate CombinationCausalityassessment methodsHumansChemical and Drug Induced Liver InjuryCyproteroneResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being